Université de Liège. Service de Cardiologie, CHC MontLégia, Liège, Belgium.
Faculté de Médecine. Département des sciences cliniques, Université de Liège, Liège, Belgium.
Acta Cardiol. 2021 Jul;76(5):461-463. doi: 10.1080/00015385.2020.1870194. Epub 2021 Jan 13.
Atrial fibrillation and diabetes: time to reconsider duration of the disease to evaluate the bleeding risk? Impact of diabetes status in patients suffering of non-valvular atrial fibrillation requiring anticoagulation have been analysed previously and risk/benefit balance of NOACs have been confirmed in these patients. The implication of that pathology in the evaluation of the thrombotic risk is discussed but more importantly bleeding risk in this growing population is analysed, perhaps neglected until now.
是否需要重新考虑疾病持续时间以评估出血风险？此前已经分析了糖尿病状态对需要抗凝治疗的非瓣膜性心房颤动患者的影响，并且已经在这些患者中证实了新型口服抗凝药物的风险/获益平衡。该病理学在血栓形成风险评估中的意义正在讨论中，但更重要的是，在这个不断增长的人群中分析了出血风险，这也许是迄今为止被忽视的问题。
